Agomab management to participate in upcoming investor conferences
Agomab Therapeutics NV says members of its management team will participate in upcoming investor conferences.
Antwerp, Belgium, September 3, 2026 — Agomab Therapeutics NV NASDAQ:AGMB (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming investor conferences:About AgomabAgomab is a…